Developer docs
API playgroundTry for free, no card

Search company profiles

Innopsys

Full company profile

uuid000koy3

Namestring
Innopsys
Legal namestring
INNOPSYS SAS
Websiteurl
innopsys.com
Company typeenum
Private
Founded yearint
1999
Descriptiontext

Innopsys is a French scientific-instrument manufacturer founded in 1999 and headquartered in Carbonne, France, that designs, manufactures, and sells fluorescence detection systems and associated software for biotechnology and medical research laboratories. Its product portfolio is organized around two proprietary technology lines: the InnoScan microarray scanner family — launched in 2006 and including the InnoScan 710 (visible 2-color), InnoScan 710-IR (near-infrared), and InnoScan 1100 (3-color confocal with autoloader) — and the InnoQuant fluorescence slide scanner launched in 2023 that extends line-scanning architecture into tissue multiplexing and whole-slide immunocytochemistry imaging. Both product families share a laser-illuminated, photomultiplier-based line-scanning detection platform, with MAPIX software providing acquisition and quantification, and outputs are compatible with mainstream analysis environments (QuPath, Fiji, HALO). Key technical differentiators include single-pass acquisition that eliminates tiling and stitching artifacts, simultaneous 4-channel fluorescence detection with 98% field uniformity, dynamic content-based focusing, and patented XY motorisation enabling 10–35 lines per second scanning speed. The company is ISO 13485:2016 certified for medical-device quality management since 2009 and reinvests roughly 30% of turnover annually into R&D.

The business model is hardware-centric: scientific instruments are sold to academic and private research laboratories, hospitals, and biotech companies, with recurring revenue from technical support, preventive maintenance, installation, and training services. Pricing is quote-based rather than publicly disclosed. Go-to-market combines a worldwide distribution network covering more than 50 countries with a wholly-owned US commercial subsidiary (Innopsys Inc, Chicago) for direct North American sales and support, complemented by remote and on-site technical support through local partners. The customer base spans life-science research (proteomics, glycomics, genomics, drug discovery), clinical diagnostics and translational research, and neuroscience/CNS imaging — anchored by reference users such as Utrecht University and Utrecht Institute for Pharmaceutical Sciences. Innopsys is a privately held, founder/management-led French SAS (Stéphane Le Brun, CEO) with no disclosed external funding rounds, a small SAS capital base, and a multidisciplinary team of scientists and engineers specializing in optics, micromechanics, electronics, computing, nanotechnology, and biology; all manufacturing occurs on the Carbonne site.

Short descriptiontext

Innopsys is a French scientific-instrument manufacturer, founded in 1999 and based in Carbonne, that designs and produces fluorescence detection scanners — the InnoScan microarray line and the InnoQuant tissue slide scanner — together with MAPIX acquisition software, serving biotech, pharmaceutical, clinical, and academic research laboratories in more than 50 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCarbonne, France
HQ citystring
Carbonne
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
microarray scanners, fluorescence slide scanners, tissue imaging instruments, biotech lab equipment, scientific imaging devices
Industry3 codes
PRIMARYHLAGAIAE
Microscopy, Imaging & Flow Cytometry Instruments
SECONDARYHLAAALAL
Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays)
SECONDARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
NAICS code1 code
  • Analytical Laboratory Instrument Manufacturing334516
SIC code1 code
  • Laboratory Analytical Instruments3826
Product category
Scientific Imaging Instruments
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Scientific instrumentation hardware sales
TypeHardware Sales
Description

Innopsys designs, manufactures and sells scientific instruments including microarray scanners (InnoScan series) and fluorescence slide scanners (InnoQuant). Products are sold to research laboratories, hospitals and biotech companies globally.

innopsys.com
2Technical support and maintenance services
TypeProfessional Services
Description

Technical customer support including preventive maintenance, one-off maintenance, remote diagnostics, installation and training services.

innopsys.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1InnoScan
Description

Series of microarray scanners for fluorescence detection used in genomics, proteomics, and various life science applications.

innopsys.com
+2 more records
Core offering1 text field

Innopsys designs, manufactures, and sells fluorescence-based scientific instruments and associated software for biotechnological and medical research laboratories. Its portfolio includes the InnoScan series of microarray scanners (InnoScan 710, InnoScan 710-IR, InnoScan 1100) for proteomics, glycomics and genomics applications, and the InnoQuant tile-free whole-slide fluorescence scanner for tissue multiplexing and immunocytochemistry. The MAPIX image acquisition and spot quantification software complements the hardware offering.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 98% field uniformity across entire slide
+5 more records
Product overview1 text field

Innopsys offers two distinct product lines for fluorescence-based biological imaging: the InnoScan microarray scanner series (launched 2006) for genomic and proteomic applications, and the InnoQuant fluorescence slide scanner (launched 2023) for tissue multiplexing. The InnoScan series includes the InnoScan 710 (2-color, visible spectrum), InnoScan 710-IR (infrared, 2-color), and InnoScan 1100 (3-color confocal) models. These microarray scanners are complemented by MAPIX acquisition and analysis software. InnoQuant represents the company's expansion into tissue imaging, featuring single-pass, tile-free whole-slide acquisition with 4-channel simultaneous detection and compatibility with standard analysis tools like QuPath, Fiji, and HALO.

Product and service5 records
1InnoQuant Fluorescence Slide Scanner
CategoryFluorescence Slide Scanner
Description

Quantitative fluorescence slide scanner for tissue multiplexing using single-pass acquisition to capture whole-slide images without tiling, stitching, or shading correction. Features 4-channel simultaneous detection (375nm UV, 488nm, 555nm, 640nm) with 0.5 µm/pixel resolution equivalent to 20x magnification, delivering artifact-free images in a single field of view with 98% uniformity. Targeted at research and clinical laboratories performing biomarker quantification and multiplex tissue analysis.

2InnoScan 1100 Microarray Scanner
CategoryMicroarray Scanner
Description

A 3-color ultra-high resolution microarray scanner with 0.5 µm pixel size (20x microscope magnification), featuring confocal detection with 3 analog PMTs, real-time autofocus, and a 24-slide autoloader (AL version) for high-throughput applications. Compatible with standard microscope slides and various fluorophores (Cy2/3/5, Alexa Fluor series). Targeted at genomics, proteomics and high-throughput microarray workflows in research laboratories.

3InnoScan 710-IR Microarray Scanner
CategoryMicroarray Scanner
Description

An infrared microarray scanner featuring dual laser wavelengths (670nm, 785nm) with confocal detection using 2 PMTs, capable of scanning slides at 10 µm/pixel in less than 4 minutes. NIR detection dramatically decreases background issues from nitrocellulose supports, improving sensitivity for protein interaction assays. Ideal for routine microarray reading and protein array applications.

4InnoScan 710 Microarray Scanner
CategoryMicroarray Scanner
Description

A two-color microarray scanner with laser excitation at 532nm and 635nm, featuring patented XY motorization for fastest scanning on the market (10-35 lines/second). Capable of reading medium density microarrays at 3 µm/pixel maximum resolution with barcode reader for traceable results. Targeted at research laboratories performing routine DNA and protein microarray reading.

5MAPIX Software
CategoryAcquisition and Analysis Software
Description

Image acquisition and spot quantification software used with InnoScan microarray scanners and InnoQuant fluorescence slide scanners. Enables automated image acquisition and multi-channel image analysis, with multiresolution TIFF outputs compatible with QuPath, Fiji, and HALO. Targeted at laboratories running microarray and tissue imaging experiments.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-16
Description

Collaborative development of integrated liquid biopsy workflow combining SmartCatch's X-Tracker technology with InnoQuant scanner for CTC and CAC detection. Joint application note released showcasing workflow from cell capture to imaging and open-source analysis.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-01
Description

Long-term collaboration with Robert de Vries' lab at Utrecht University for influenza virus research. Lab serves as early adopter of InnoScan series and now InnoQuant for glycan receptor studies and tissue imaging.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration on comparison study of InnoQuant vs widefield microscopy for CNS cells quantification. Translucence provides AI-driven quantification analysis using InnoQuant images for microglial inflammation studies.

4GdR Imabio (Groupement de Recherche)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Innopsys became partner of GdR Imabio, a French research network dedicated to promoting collaboration and innovation in advanced bioimaging techniques for life sciences.

innopsys.com
5Paralab
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Spanish distribution partner representing Innopsys at FENS Forum 2026 conference in Barcelona.

innopsys.com
Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Li-Cor manufactures Odyssey and Aeris infrared/near-infrared fluorescence imaging systems and microarray scanners that directly overlap with Innopsys' InnoScan 710-IR product line, especially for nitrocellulose-based protein microarrays and membrane imaging.

TypeDirect peer
Description

Molecular Devices offers GenePix microarray scanners and high-content imaging platforms that compete with Innopsys' InnoScan series for genomic/proteomic array readout and with fluorescence imaging workflows more broadly.

TypeDirect peer
Description

Akoya Biosciences' PhenoCycler/CODEX and Phenoptics multiplex tissue imaging platforms are the most direct competitors to Innopsys' InnoQuant for spatial biology, multiplex immunofluorescence and quantitative biomarker imaging in tissue.

TypeDirect peer
Description

Hamamatsu produces NanoZoomer whole-slide scanners and high-sensitivity fluorescence imaging systems used in digital pathology and tissue imaging, competing with InnoQuant on slide-scanning throughput and quantitative fluorescence capability.

TypeBroad incumbent
Description

Leica's Aperio GT and STELLARIS confocal/TIRF systems cover whole-slide scanning and high-end fluorescence microscopy, making Leica a broad incumbent whose instruments overlap with both Innopsys' microarray scanners and tissue-imaging workflows.

TypeBroad incumbent
Description

ZEISS offers Axio Scan.Z1 whole-slide scanners and a broad portfolio of fluorescence/confocal microscopes, competing with Innopsys across both microarray readout (via research microscopy) and tissue/multiplex fluorescence imaging.

TypeBroad incumbent
Description

Thermo Fisher's life-sciences instrumentation portfolio — including fluorescence imagers, microarrays and high-content screening systems — competes broadly with Innopsys across genomics, proteomics and translational tissue imaging.

TypeBroad incumbent
Description

Bio-Rad supplies Protein Microarray and imaging-related life-science instruments, and its broader analytical workflow tools (ChemiDoc, etc.) overlap with Innopsys' fluorescence and protein-array use-cases in research labs.

TypeEmerging player
Description

Standard BioTools provides mass cytometry and imaging mass cytometry (Hyperion) systems for highly multiplexed tissue analysis, competing with Innopsys' InnoQuant in translational tissue-biomarker applications from an emerging-player position.

TypeBroad incumbent
Description

Revvity offers a broad life-sciences instrumentation portfolio including microarray scanners and high-content imaging platforms that overlap with both Innopsys' microarray and tissue-imaging product lines.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Innopsys

Scientific Imaging Instrumentsinnopsys.com

Innopsys is a French scientific-instrument manufacturer, founded in 1999 and based in Carbonne, that designs and produces fluorescence detection scanners — the InnoScan microarray line and the InnoQuant tissue slide scanner — together with MAPIX acquisition software, serving biotech, pharmaceutical, clinical, and academic research laboratories in more than 50 countries.

What Innopsys does

Innopsys is a French scientific-instrument manufacturer founded in 1999 and headquartered in Carbonne, France, that designs, manufactures, and sells fluorescence detection systems and associated software for biotechnology and medical research laboratories. Its product portfolio is organized around two proprietary technology lines: the InnoScan microarray scanner family — launched in 2006 and including the InnoScan 710 (visible 2-color), InnoScan 710-IR (near-infrared), and InnoScan 1100 (3-color confocal with autoloader) — and the InnoQuant fluorescence slide scanner launched in 2023 that extends line-scanning architecture into tissue multiplexing and whole-slide immunocytochemistry imaging. Both product families share a laser-illuminated, photomultiplier-based line-scanning detection platform, with MAPIX software providing acquisition and quantification, and outputs are compatible with mainstream analysis environments (QuPath, Fiji, HALO). Key technical differentiators include single-pass acquisition that eliminates tiling and stitching artifacts, simultaneous 4-channel fluorescence detection with 98% field uniformity, dynamic content-based focusing, and patented XY motorisation enabling 10–35 lines per second scanning speed. The company is ISO 13485:2016 certified for medical-device quality management since 2009 and reinvests roughly 30% of turnover annually into R&D.

The business model is hardware-centric: scientific instruments are sold to academic and private research laboratories, hospitals, and biotech companies, with recurring revenue from technical support, preventive maintenance, installation, and training services. Pricing is quote-based rather than publicly disclosed. Go-to-market combines a worldwide distribution network covering more than 50 countries with a wholly-owned US commercial subsidiary (Innopsys Inc, Chicago) for direct North American sales and support, complemented by remote and on-site technical support through local partners. The customer base spans life-science research (proteomics, glycomics, genomics, drug discovery), clinical diagnostics and translational research, and neuroscience/CNS imaging — anchored by reference users such as Utrecht University and Utrecht Institute for Pharmaceutical Sciences. Innopsys is a privately held, founder/management-led French SAS (Stéphane Le Brun, CEO) with no disclosed external funding rounds, a small SAS capital base, and a multidisciplinary team of scientists and engineers specializing in optics, micromechanics, electronics, computing, nanotechnology, and biology; all manufacturing occurs on the Carbonne site.

Innopsys firmographics

Firmographics
Name
Innopsys
Legal name
INNOPSYS SAS
Website
https://innopsys.com
Company type
Private
Founded year
1999
Operating status
Operating
Headcount range
11–50 employees
Short description
Innopsys is a French scientific-instrument manufacturer, founded in 1999 and based in Carbonne, that designs and produces fluorescence detection scanners — the InnoScan microarray line and the InnoQuant tissue slide scanner — together with MAPIX acquisition software, serving biotech, pharmaceutical, clinical, and academic research laboratories in more than 50 countries.
Ownership category
akta.pro rank

Innopsys industry classification

Industry
Product category
Scientific Imaging Instruments
NAICS
Analytical Laboratory Instrument Manufacturing (334516)
SIC
Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAGAIAE
Microscopy, Imaging & Flow Cytometry Instruments
SECONDARYHLAAALAL
Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays)
SECONDARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)

Keywords

  • Microarray scanners
  • Fluorescence slide scanners
  • Tissue imaging instruments
  • Biotech lab equipment
  • Scientific imaging devices

Where Innopsys is headquartered

Location

Headquarters

HQ city
Carbonne
HQ country
France
HQ region
Europe

Offices2 records

Markets served

Innopsys business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. Scientific instrumentation hardware sales: Innopsys designs, manufactures and sells scientific instruments including microarray scanners (InnoScan series) and fluorescence slide scanners (InnoQuant). Products are sold to research laboratories, hospitals and biotech companies globally.
  2. Technical support and maintenance services: Technical customer support including preventive maintenance, one-off maintenance, remote diagnostics, installation and training services.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Innopsys product offering

Product offering

Core offering

Innopsys designs, manufactures, and sells fluorescence-based scientific instruments and associated software for biotechnological and medical research laboratories. Its portfolio includes the InnoScan series of microarray scanners (InnoScan 710, InnoScan 710-IR, InnoScan 1100) for proteomics, glycomics and genomics applications, and the InnoQuant tile-free whole-slide fluorescence scanner for tissue multiplexing and immunocytochemistry. The MAPIX image acquisition and spot quantification software complements the hardware offering.

Product overview

Innopsys offers two distinct product lines for fluorescence-based biological imaging: the InnoScan microarray scanner series (launched 2006) for genomic and proteomic applications, and the InnoQuant fluorescence slide scanner (launched 2023) for tissue multiplexing. The InnoScan series includes the InnoScan 710 (2-color, visible spectrum), InnoScan 710-IR (infrared, 2-color), and InnoScan 1100 (3-color confocal) models. These microarray scanners are complemented by MAPIX acquisition and analysis software. InnoQuant represents the company's expansion into tissue imaging, featuring single-pass, tile-free whole-slide acquisition with 4-channel simultaneous detection and compatibility with standard analysis tools like QuPath, Fiji, and HALO.

Differentiator

Problem solved

Functional benefit

Brands

  • InnoScan: Series of microarray scanners for fluorescence detection used in genomics, proteomics, and various life science applications.
  • InnoQuant
  • MAPIX

Products and services

  • InnoQuant Fluorescence Slide Scanner Quantitative fluorescence slide scanner for tissue multiplexing using single-pass acquisition to capture whole-slide images without tiling, stitching, or shading correction. Features 4-channel simultaneous detection (375nm UV, 488nm, 555nm, 640nm) with 0.5 µm/pixel resolution equivalent to 20x magnification, delivering artifact-free images in a single field of view with 98% uniformity. Targeted at research and clinical laboratories performing biomarker quantification and multiplex tissue analysis.
  • InnoScan 1100 Microarray Scanner A 3-color ultra-high resolution microarray scanner with 0.5 µm pixel size (20x microscope magnification), featuring confocal detection with 3 analog PMTs, real-time autofocus, and a 24-slide autoloader (AL version) for high-throughput applications. Compatible with standard microscope slides and various fluorophores (Cy2/3/5, Alexa Fluor series). Targeted at genomics, proteomics and high-throughput microarray workflows in research laboratories.
  • InnoScan 710-IR Microarray Scanner An infrared microarray scanner featuring dual laser wavelengths (670nm, 785nm) with confocal detection using 2 PMTs, capable of scanning slides at 10 µm/pixel in less than 4 minutes. NIR detection dramatically decreases background issues from nitrocellulose supports, improving sensitivity for protein interaction assays. Ideal for routine microarray reading and protein array applications.
  • InnoScan 710 Microarray Scanner A two-color microarray scanner with laser excitation at 532nm and 635nm, featuring patented XY motorization for fastest scanning on the market (10-35 lines/second). Capable of reading medium density microarrays at 3 µm/pixel maximum resolution with barcode reader for traceable results. Targeted at research laboratories performing routine DNA and protein microarray reading.
  • MAPIX Software Image acquisition and spot quantification software used with InnoScan microarray scanners and InnoQuant fluorescence slide scanners. Enables automated image acquisition and multi-channel image analysis, with multiresolution TIFF outputs compatible with QuPath, Fiji, and HALO. Targeted at laboratories running microarray and tissue imaging experiments.

Quantifiable outcome

  • 98% field uniformity across entire slide
  • +5 more outcomes

Companies that use Innopsys

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Innopsys technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability4 records

Feature7 records

Innopsys partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • SmartCatchcoreStrategic or Co-development Partner · 16 June 2026Collaborative development of integrated liquid biopsy workflow combining SmartCatch's X-Tracker technology with InnoQuant scanner for CTC and CAC detection. Joint application note released showcasing workflow from cell capture to imaging and open-source analysis.
  • Utrecht UniversitycoreStrategic or Co-development Partner · 1 June 2026Long-term collaboration with Robert de Vries' lab at Utrecht University for influenza virus research. Lab serves as early adopter of InnoScan series and now InnoQuant for glycan receptor studies and tissue imaging.
  • Translucence BiosystemscoreStrategic or Co-development PartnerCollaboration on comparison study of InnoQuant vs widefield microscopy for CNS cells quantification. Translucence provides AI-driven quantification analysis using InnoQuant images for microglial inflammation studies.
  • GdR Imabio (Groupement de Recherche)minorStrategic or Co-development PartnerInnopsys became partner of GdR Imabio, a French research network dedicated to promoting collaboration and innovation in advanced bioimaging techniques for life sciences.
  • ParalabcoreChannel Partner/ Reseller/ DistributorSpanish distribution partner representing Innopsys at FENS Forum 2026 conference in Barcelona.

Scale indicators3 records

Recent moves9 records

Expansion highlights5 records

Innopsys competitors and assessment

Company assessment

Direct peers

  • Li-Cor Biosciences: Li-Cor manufactures Odyssey and Aeris infrared/near-infrared fluorescence imaging systems and microarray scanners that directly overlap with Innopsys' InnoScan 710-IR product line, especially for nitrocellulose-based protein microarrays and membrane imaging.
  • Molecular Devices (Danaher): Molecular Devices offers GenePix microarray scanners and high-content imaging platforms that compete with Innopsys' InnoScan series for genomic/proteomic array readout and with fluorescence imaging workflows more broadly.
  • Akoya Biosciences: Akoya Biosciences' PhenoCycler/CODEX and Phenoptics multiplex tissue imaging platforms are the most direct competitors to Innopsys' InnoQuant for spatial biology, multiplex immunofluorescence and quantitative biomarker imaging in tissue.
  • Hamamatsu Photonics: Hamamatsu produces NanoZoomer whole-slide scanners and high-sensitivity fluorescence imaging systems used in digital pathology and tissue imaging, competing with InnoQuant on slide-scanning throughput and quantitative fluorescence capability.

Broad incumbents

  • Leica Microsystems (Danaher): Leica's Aperio GT and STELLARIS confocal/TIRF systems cover whole-slide scanning and high-end fluorescence microscopy, making Leica a broad incumbent whose instruments overlap with both Innopsys' microarray scanners and tissue-imaging workflows.
  • ZEISS (Carl Zeiss Microscopy): ZEISS offers Axio Scan.Z1 whole-slide scanners and a broad portfolio of fluorescence/confocal microscopes, competing with Innopsys across both microarray readout (via research microscopy) and tissue/multiplex fluorescence imaging.
  • Thermo Fisher Scientific: Thermo Fisher's life-sciences instrumentation portfolio — including fluorescence imagers, microarrays and high-content screening systems — competes broadly with Innopsys across genomics, proteomics and translational tissue imaging.
  • Bio-Rad Laboratories: Bio-Rad supplies Protein Microarray and imaging-related life-science instruments, and its broader analytical workflow tools (ChemiDoc, etc.) overlap with Innopsys' fluorescence and protein-array use-cases in research labs.
  • Revvity (formerly PerkinElmer Life Sciences): Revvity offers a broad life-sciences instrumentation portfolio including microarray scanners and high-content imaging platforms that overlap with both Innopsys' microarray and tissue-imaging product lines.

Emerging players

  • Standard BioTools (formerly Fluidigm): Standard BioTools provides mass cytometry and imaging mass cytometry (Hyperion) systems for highly multiplexed tissue analysis, competing with Innopsys' InnoQuant in translational tissue-biomarker applications from an emerging-player position.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Innopsys social profiles

Digital presence

Innopsys compliance and trust

Trust signal

Compliance1 record

Innopsys financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Innopsys leadership team

Management profile

Number of profiles

Profiles1 record

Innopsys subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Innopsys funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Innopsys M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Innopsys

What does Innopsys do?

Innopsys designs, manufactures, and sells fluorescence-based scientific instruments and associated software for biotechnological and medical research laboratories. Its portfolio includes the InnoScan series of microarray scanners (InnoScan 710, InnoScan 710-IR, InnoScan 1100) for proteomics, glycomics and genomics applications, and the InnoQuant tile-free whole-slide fluorescence scanner for tissue multiplexing and immunocytochemistry. The MAPIX image acquisition and spot quantification software complements the hardware offering.

Is Innopsys a public or private company?

Innopsys is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Innopsys founded?

Innopsys was founded in 1999. It employs 11 to 50 people.

Where is Innopsys based?

Innopsys is headquartered in Carbonne, France, in the Europe region.

How does Innopsys make money?

Two revenue lines are on record. Scientific instrumentation hardware sales are the primary driver. The others are technical support and maintenance services.

Who are Innopsys's main competitors?

Direct peers on record are Li-Cor Biosciences, Molecular Devices (Danaher), Akoya Biosciences and Hamamatsu Photonics. Broad incumbents are Leica Microsystems (Danaher), ZEISS (Carl Zeiss Microscopy), Thermo Fisher Scientific, Bio-Rad Laboratories and Revvity (formerly PerkinElmer Life Sciences). Standard BioTools (formerly Fluidigm) is listed as an emerging player.

Does Innopsys have an API?

No public API is recorded for Innopsys.

What industry is Innopsys in?

Innopsys's product category is Scientific Imaging Instruments. Its primary akta.pro industry code is HLAGAIAE, Microscopy, Imaging & Flow Cytometry Instruments, with a secondary code of HLAAALAL, Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays). Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales